Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T53389 | Target Info | |||
Target Name | TGF-beta receptor type I (TGFBR1) | ||||
Synonyms | Type I TGFbeta receptor kinase; Transforming growth factor-beta receptor type I; TbetaRI; TbetaR-I; TGFR-1; TGF-beta type I receptor; TGF-beta receptor type-1; Serine/threonine-protein kinase receptor R4; SKR4; Activin receptor-like kinase 5; Activin A receptor type II-like protein kinase of 53kD; ALK5; ALK-5 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | TGFBR1 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 1 Acyltransferases | + | |||
Interacting Target Name | TNF receptor-associated factor 6 (TRAF6) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RNF85; RING-type E3 ubiquitin transferase TRAF6; RING finger protein 85; Interleukin-1 signal transducer; E3 ubiquitin-protein ligase TRAF6 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [3] | |||
4 | Affinity Capture-Western | [4] | |||
5 | Co-localization | [4] | |||
Auxiliary transporters | [+] 1 Auxiliary transporters | + | |||
Interacting Target Name | Neuropilin-1 (NRP1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | VEGF165R; Vascular endothelial cell growth factor 165 receptor; Platelet-derived endothelial cell growth factor receptor; NRP; Membrane-bound; CD304 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [5] | |||
2 | Reconstituted Complex | [6] | |||
Growth factors | [+] 1 Growth factors | + | |||
Interacting Target Name | Transforming growth factor beta 1 (TGFB1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transforming growth factor beta-1 proprotein; Transforming growth factor beta-1; TGF-beta1; TGF-beta 1; TGFB | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Affinity Capture-Western | [8] | |||
3 | Reconstituted Complex | [9] | |||
Heat shock proteins | [+] 1 Heat shock proteins | + | |||
Interacting Target Name | Heat shock protein 90 alpha (HSP90A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Renal carcinoma antigen NY-REN-38; LPS-associated protein 2; Lipopolysaccharide-associated protein 2; LAP-2; HSPCA; HSPC1; HSP90A; HSP86; HSP 86; Heat shock protein HSP 90-alpha; Heat shock 86 kDa | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Reconstituted Complex | [10] | |||
Isomerases | [+] 1 Isomerases | + | |||
Interacting Target Name | FK506-binding protein 1A (FKBP1A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Rotamase; PPIase FKBP1A; Peptidyl-prolyl cis-trans isomerase FKBP1A; Immunophillin FKBP; Immunophilin FKBP12; FKBP-1A; FKBP-12; FKBP12; FKBP1; FK-binding protein 12; Calstabin-1; 12 kDa FKBP; 12 kDa FK506-binding protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [11] | |||
2 | Yeast two hybrid | [11] | |||
Kinases | [+] 1 Kinases | + | |||
Interacting Target Name | TGF-beta receptor type II (TGFBR2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transforminggrowth factor-beta receptor type II; Transforming growth factor-beta receptor type II; TGFR-2; TGF-beta type II receptor; TGF-beta receptor type-2; TbetaR-II | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [12] | |||
2 | Affinity Capture-Western | [13] | |||
3 | Affinity Capture-Western | [14] | |||
4 | Affinity Capture-Western | [15] | |||
5 | Co-fractionation | [16] | |||
6 | Yeast two hybrid | [17] | |||
Transcription regulators | [+] 3 Transcription regulators | + | |||
Interacting Protein Name | Mothers against decapentaplegic homolog 2 (SMAD2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | JV18; JV18.1; MADH2; MADR2; hMAD.2; hSMAD2 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [18] | |||
2 | Affinity Capture-Western | [19] | |||
3 | Affinity Capture-Western | [20] | |||
4 | Biochemical Activity | [21] | |||
5 | Co-fractionation | [16] | |||
Interacting Target Name | Mothers against decapentaplegic homolog 7 (SMAD7) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Smad7; SMAD family member 7; SMAD 7; Mothers against DPP homolog 8; Mothers against decapentaplegic homolog 8; MAD homolog 8; hSMAD7 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [22] | |||
2 | Co-localization | [23] | |||
3 | Reconstituted Complex | [24] | |||
Interacting Target Name | Mothers against decapentaplegic homolog 3 (SMAD3) | Preclinical Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TGF-beta response effector Smad3; Smad3; SMAD family member 3; SMAD 3; Mothers against DPP homolog 3; MMad3; MADH3; Mad3; MAD homolog 3; JV15-2; HSMAD3; HMAD-3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [19] | |||
2 | Biochemical Activity | [21] | |||
Other proteins | [+] 2 Other proteins | + | |||
Interacting Target Name | Endoglin CD105 (ENG) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | END; CD105 antigen; CD105 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [25] | |||
2 | Affinity Capture-Western | [26] | |||
3 | Biochemical Activity | [25] | |||
Interacting Target Name | Extracellular matrix receptor III (CD44) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Phagocytic glycoprotein I; Phagocytic glycoprotein 1; PGP-I; PGP-1; MIC4; MDU3; MDU2; LHR; Hyaluronate receptor; HUTCH-I; Hermes antigen; Heparan sulfate proteoglycan; GP90 lymphocyte homing/adhesion receptor; Extracellular matrix receptor-III; Epican; ECMR-III; CDw44; CD44 antigen | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [9] | |||
2 | Reconstituted Complex | [27] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | RanBPM interacts with TRI, TRAF6 and curbs TGF induced nuclear accumulation of TRI. Cell Signal. 2014 Jan;26(1):162-72. | ||||
REF 2 | TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol Cell. 2008 Sep 26;31(6):918-24. | ||||
REF 3 | TNF receptor-associated factor 6 (TRAF6) mediates the angiotensin-induced non-canonical TGF- pathway activation of c-kit(+) cardiac stem cells. Am J Transl Res. 2015 Nov 15;7(11):2233-43. | ||||
REF 4 | TRAF6 promotes TGF-induced invasion and cell-cycle regulation via Lys63-linked polyubiquitination of Lys178 in TGF type I receptor. Cell Cycle. 2015;14(4):554-65. | ||||
REF 5 | Neuropilin-1 mediates divergent R-Smad signaling and the myofibroblast phenotype. J Biol Chem. 2010 Oct 8;285(41):31840-8. | ||||
REF 6 | Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. Carcinogenesis. 2011 Apr;32(4):613-21. | ||||
REF 7 | Determination of type I receptor specificity by the type II receptors for TGF-beta or activin. Science. 1993 Nov 5;262(5135):900-2. | ||||
REF 8 | Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2626-31. | ||||
REF 9 | Bikunin down-regulates heterodimerization between CD44 and growth factor receptors and subsequently suppresses agonist-mediated signaling. J Cell Biochem. 2005 Apr 1;94(5):995-1009. | ||||
REF 10 | Critical regulation of TGFbeta signaling by Hsp90. Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9244-9. | ||||
REF 11 | Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12. Science. 1994 Jul 29;265(5172):674-6. | ||||
REF 12 | TSC-22 promotes transforming growth factor -mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity. Mol Cell Biol. 2011 Sep;31(18):3700-9. | ||||
REF 13 | Transforming growth factor-beta (TGF-beta1) activates TAK1 via TAB1-mediated autophosphorylation, independent of TGF-beta receptor kinase activity in mesangial cells. J Biol Chem. 2009 Aug 14;284(33):22285-96. | ||||
REF 14 | Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling. J Biol Chem. 2009 Oct 30;284(44):30097-104. | ||||
REF 15 | Suppressor of cytokine signaling 1 is a positive regulator of TGF--induced prostaglandin production in human follicular dendritic cell-like cells. J Immunol. 2015 May 1;194(9):4287-97. | ||||
REF 16 | Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. J Biol Chem. 2001 Mar 2;276(9):6727-38. | ||||
REF 17 | Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptor. J Biol Chem. 1995 Mar 10;270(10):5625-30. | ||||
REF 18 | Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway. J Clin Invest. 2009 Feb;119(2):349-61. | ||||
REF 19 | Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. Science. 2003 Jan 24;299(5606):574-7. | ||||
REF 20 | 15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-, SMAD2/3, and TAP63 proteins. J Biol Chem. 2013 Jul 5;288(27):19484-502. | ||||
REF 21 | Casein kinase 2 (CK2) phosphorylates the deubiquitylase OTUB1 at Ser16 to trigger its nuclear localization. Sci Signal. 2015 Apr 14;8(372):ra35. | ||||
REF 22 | Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling. J Biol Chem. 2004 Jul 23;279(30):31568-74. | ||||
REF 23 | Tollip, an intracellular trafficking protein, is a novel modulator of the transforming growth factor- signaling pathway. J Biol Chem. 2012 Nov 16;287(47):39653-63. | ||||
REF 24 | The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell. 1997 Jun 27;89(7):1165-73. | ||||
REF 25 | Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. J Biol Chem. 2002 Aug 9;277(32):29197-209. | ||||
REF 26 | S-endoglin expression is induced in senescent endothelial cells and contributes to vascular pathology. Circ Res. 2008 Dec 5;103(12):1383-92. | ||||
REF 27 | Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. J Biol Chem. 2002 Oct 18;277(42):39703-12. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.